HupA is an important compound that is used to treat Alzheimer's disease (AD) in China as a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with low toxicity [3]–[6]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.